New

Organ Transplant Immunosuppressant Drugs Market

2021

Organ Transplant Immunosuppressant Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis by THERAPEUTICS (Heart Transplant, Lung Transplant, Kidney Transplant, Liver Transplant); COMMERCIALIZED PRODUCTS (Zenapax, Prograf, Cellcept, Myfortic, Neoral)

| Report Code: TIPRE00011945 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Organ Transplant Immunosuppressant Drugs Market 2028 By THERAPEUTICS, COMMERCIALIZED PRODUCTS | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Organ transplant immunosuppressant drugs are the category of drugs that are administered to minimize the chances of organ rejection after transplantation. Also, when a person undergoes any transplantation, the body recognizes the transplant as foreign tissue and attacks it, resulting in dismissal. These drugs dilute the immune system, and hence reducing the reaction towards the transplant.

MARKET DYNAMICS

The organ transplant immunosuppressant drugs market is driving due to the advancements made in tissue engineering and organ transplantations. However, the lack of availability of organs and high cost of transplantation are the limitations for the growth of this market during the forecast period. Moreover, kidney transplant has a well-established market although heart transplant is expected to have potential growth.

MARKET SCOPE

The "Organ Transplant Immunosuppressant Drugs Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of organ transplant immunosuppressant drugs market with detailed market segmentation by therapeutics and commercialized products. The organ transplant immunosuppressant drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in organ transplant immunosuppressant drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The organ transplant immunosuppressant drugs market is segmented on the basis of therapeutics and commercialized products. Based on therapeutics, the market is segmented as heart transplant, lung transplant, kidney transplant and liver transplant. On the basis of commercialized products, the market is categorized as zenapax, prograf, cellcept, myfortic and neoral.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the organ transplant immunosuppressant drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The organ transplant immunosuppressant drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting organ transplant immunosuppressant drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the organ transplant immunosuppressant drugs market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the organ transplant immunosuppressant drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from organ transplant immunosuppressant drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for organ transplant immunosuppressant drugs in the global market. Below mentioned is the list of few companies engaged in the organ transplant immunosuppressant drugs market.

The report also includes the profiles of key players in organ transplant immunosuppressant drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   AstellasPharma
  •   Genzyme Corporation
  •   Accord Healthcare Ltd.
  •   Watson Pharmaceuticals, Inc.
  •   Novartis AG
  •   Mylan Laboratories, Inc.
  •   GlaxoSmithKline plc
  •   Hoffman La Roche


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Organ Transplant Immunosuppressant Drugs Market - By THERAPEUTICS
1.3.2 Organ Transplant Immunosuppressant Drugs Market - By COMMERCIALIZED PRODUCTS
1.3.3 Organ Transplant Immunosuppressant Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS - GLOBAL MARKET OVERVIEW
6.2. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - THERAPEUTICS
7.1. OVERVIEW
7.2. THERAPEUTICS MARKET FORECASTS AND ANALYSIS
7.3. HEART TRANSPLANT
7.3.1. Overview
7.3.2. Heart Transplant Market Forecast and Analysis
7.4. LUNG TRANSPLANT
7.4.1. Overview
7.4.2. Lung Transplant Market Forecast and Analysis
7.5. KIDNEY TRANSPLANT
7.5.1. Overview
7.5.2. Kidney Transplant Market Forecast and Analysis
7.6. LIVER TRANSPLANT
7.6.1. Overview
7.6.2. Liver Transplant Market Forecast and Analysis
8. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - COMMERCIALIZED PRODUCTS
8.1. OVERVIEW
8.2. COMMERCIALIZED PRODUCTS MARKET FORECASTS AND ANALYSIS
8.3. ZENAPAX
8.3.1. Overview
8.3.2. Zenapax Market Forecast and Analysis
8.4. PROGRAF
8.4.1. Overview
8.4.2. Prograf Market Forecast and Analysis
8.5. CELLCEPT
8.5.1. Overview
8.5.2. Cellcept Market Forecast and Analysis
8.6. MYFORTIC
8.6.1. Overview
8.6.2. Myfortic Market Forecast and Analysis
8.7. NEORAL
8.7.1. Overview
8.7.2. Neoral Market Forecast and Analysis
9. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Organ Transplant Immunosuppressant Drugs Market Overview
9.1.2 North America Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis
9.1.3 North America Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By THERAPEUTICS
9.1.4 North America Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By COMMERCIALIZED PRODUCTS
9.1.5 North America Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Organ Transplant Immunosuppressant Drugs Market
9.1.5.1.1 United States Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.1.5.1.2 United States Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.1.5.2 Canada Organ Transplant Immunosuppressant Drugs Market
9.1.5.2.1 Canada Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.1.5.2.2 Canada Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.1.5.3 Mexico Organ Transplant Immunosuppressant Drugs Market
9.1.5.3.1 Mexico Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.1.5.3.2 Mexico Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.2. EUROPE
9.2.1 Europe Organ Transplant Immunosuppressant Drugs Market Overview
9.2.2 Europe Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis
9.2.3 Europe Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By THERAPEUTICS
9.2.4 Europe Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By COMMERCIALIZED PRODUCTS
9.2.5 Europe Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Organ Transplant Immunosuppressant Drugs Market
9.2.5.1.1 Germany Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.2.5.1.2 Germany Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.2.5.2 France Organ Transplant Immunosuppressant Drugs Market
9.2.5.2.1 France Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.2.5.2.2 France Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.2.5.3 Italy Organ Transplant Immunosuppressant Drugs Market
9.2.5.3.1 Italy Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.2.5.3.2 Italy Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.2.5.4 Spain Organ Transplant Immunosuppressant Drugs Market
9.2.5.4.1 Spain Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.2.5.4.2 Spain Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.2.5.5 United Kingdom Organ Transplant Immunosuppressant Drugs Market
9.2.5.5.1 United Kingdom Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.2.5.5.2 United Kingdom Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Organ Transplant Immunosuppressant Drugs Market Overview
9.3.2 Asia-Pacific Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By THERAPEUTICS
9.3.4 Asia-Pacific Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By COMMERCIALIZED PRODUCTS
9.3.5 Asia-Pacific Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Organ Transplant Immunosuppressant Drugs Market
9.3.5.1.1 Australia Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.3.5.1.2 Australia Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.3.5.2 China Organ Transplant Immunosuppressant Drugs Market
9.3.5.2.1 China Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.3.5.2.2 China Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.3.5.3 India Organ Transplant Immunosuppressant Drugs Market
9.3.5.3.1 India Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.3.5.3.2 India Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.3.5.4 Japan Organ Transplant Immunosuppressant Drugs Market
9.3.5.4.1 Japan Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.3.5.4.2 Japan Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.3.5.5 South Korea Organ Transplant Immunosuppressant Drugs Market
9.3.5.5.1 South Korea Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.3.5.5.2 South Korea Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Overview
9.4.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By THERAPEUTICS
9.4.4 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By COMMERCIALIZED PRODUCTS
9.4.5 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Organ Transplant Immunosuppressant Drugs Market
9.4.5.1.1 South Africa Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.4.5.1.2 South Africa Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.4.5.2 Saudi Arabia Organ Transplant Immunosuppressant Drugs Market
9.4.5.2.1 Saudi Arabia Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.4.5.2.2 Saudi Arabia Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.4.5.3 U.A.E Organ Transplant Immunosuppressant Drugs Market
9.4.5.3.1 U.A.E Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.4.5.3.2 U.A.E Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Organ Transplant Immunosuppressant Drugs Market Overview
9.5.2 South and Central America Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis
9.5.3 South and Central America Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By THERAPEUTICS
9.5.4 South and Central America Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By COMMERCIALIZED PRODUCTS
9.5.5 South and Central America Organ Transplant Immunosuppressant Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Organ Transplant Immunosuppressant Drugs Market
9.5.5.1.1 Brazil Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.5.5.1.2 Brazil Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
9.5.5.2 Argentina Organ Transplant Immunosuppressant Drugs Market
9.5.5.2.1 Argentina Organ Transplant Immunosuppressant Drugs Market by THERAPEUTICS
9.5.5.2.2 Argentina Organ Transplant Immunosuppressant Drugs Market by COMMERCIALIZED PRODUCTS
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET, KEY COMPANY PROFILES
12.1. ASTELLASPHARMA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GENZYME CORPORATION
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ACCORD HEALTHCARE LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. WATSON PHARMACEUTICALS, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NOVARTIS AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MYLAN LABORATORIES, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. HOFFMAN LA ROCHE
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AstellasPharma
2. Genzyme Corporation
3. Accord Healthcare Ltd.
4. Watson Pharmaceuticals, Inc.
5. Novartis AG
6. Mylan Laboratories, Inc.
7. GlaxoSmithKline plc
8. Hoffman La Roche
TIPRE00011945
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.